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PP2ATranscription factor NFκB is activated by several processes including inﬂammation, endoplasmic-reticulum (ER)
stress, increase in Akt signaling and enhanced proteasomal degradation. Calreticulin (CRT) is an ER Ca2+-binding
chaperone that regulates many cellular processes. Gene-targeted deletion of CRT has been shown to induce ER
stress that is accompanied with a signiﬁcant increase in the proteasome activity. Loss of CRT function increases
the resistance of CRT-deﬁcient (crt−/−) cells to UV- and drug-induced apoptosis. Based on these reports we hy-
pothesized that loss of CRT will activate NFκB signaling thus contributing to enhanced resistance to apoptosis. In
contrast to our hypothesis, we observed a signiﬁcant decrease in the basal transcriptional activity of NFκB in CRT-
deﬁcient cells. Treatment with lipopolysaccharide failed to increase the transcriptional activity of NFκB in the
crt−/− cells to the same level as in thewt cells. Our data illustrate that themechanism of decreasedNFκB activity
in CRT-deﬁcient cells is mediated by a signiﬁcant increase in IκB protein expression. Furthermore, we showed a
signiﬁcant increase in protein phosphatase 2A activity inhibition which resulted in decreased IκBα protein level
in CRT-deﬁcient cells. Based on our data we concluded that loss of CRT increases the stability of IκB protein thus
reducing NFκB activity.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Calreticulin (CRT) is an endoplasmic-reticulum (ER) chaperone that
also plays an important role in the maintenance of intracellular Ca2+
homeostasis (reviewed in [1]). As a chaperone CRT is involved in the
ER quality control process during the synthesis and folding of a variety
of proteins [2]. It recognizes the terminal glucose residues at the oligo-
saccharide side chain of the newly synthesized proteins and acts as
their chaperone [3]. During the quality control process of ER, if the
protein is deemed misfolded/unfolded it will accumulate in the ER
resulting in the activation of ER stress and ER-associated protein
degradation (ERAD). Previously we demonstrated that gene-targeted
deletion of CRT leads to ER stress and activation of ubiquitin–protea-
some system of protein degradation (part of ERAD) [4,5]. We also
demonstrated that mouse embryonic ﬁbroblast (MEF) cells isolated
from CRT-deﬁcient embryos (crt−/−) show increased resistance to
UV-induced apoptosis [6]. This resistance to apoptosis is partially due
to a signiﬁcant increase in PI3-kinase/Akt activity [7] and activation ofege in Qatar, Qatar Foundation,
92 8327; fax: +974 4492 8333.
Mesaeli).
Gilgan Center for Research andthe ubiquitin–proteasome pathway [5] that induces p53 degradation
and loss of function [6]. CRT-deﬁcient cells were also reported to be
resistant to drug-induced apoptosis [8]. These data illustrate a role for
CRT in the regulation of signaling pathways involved in cell survival
and apoptosis.
NFκB pathway is one of the pathways involved in enhancing cell
survival and inhibition of apoptosis [9]. The NFκB pathway consists of
a large family of transcription factors that heterodimerize to form
transcriptionally active NFκB complex [10,11]. Themost common active
formofNFκB is a heterodimer composed of p65 andp50 [12]. In a resting
cell, this complex is restricted to the cytosol via association with inhibi-
tor of κB (IκB) proteins [10]. Upon stimulation with pro-inﬂammatory
factors such as tumor necrosis factor α (TNFα), interleukin-1 (IL-1) or
lipopolysaccharide, the IκB kinase (IKK) is activated resulting in phos-
phorylation of IκB [13]. Phosphorylated IκBs are polyubiquitinated at
conserved lysine residues and subsequently degraded by 26S protea-
some pathway [14]. Upon degradation of IκB proteins, NFκB dimer is
released and accumulates in the nucleus. In the nucleus NFκB selectively
binds to the κB consensus sequence in the promoter region of down-
stream genes and activates their transcription [12]. Activation of NFκB
is a dynamic process that can be terminated by shuttling it out of the
nucleus via association with newly synthesized IκB proteins [10,11].
NFκB has been reported to be activated due to: enhanced protea-
some activity (leading to increased IκB degradation) [14], induction of
ER stress [15], activation of PI3-kinase/Akt pathway [16,17] as well as
Table 1
Oligonucleotide sequences of primers used for real-time PCR analysis.
Gene of interest Oligonucleotide sequence
NFκB-p65-5 5′-agtggccattgtgttccgga-3′
NFκB-p65-3 5′-tcagaaggccgccgtagctg-3′
IKK-α5 5′-gatgactggagaagttcggt-3′
IKK-α3 5′-aggtccccctctctgctgtg-3′
IKK-β5 5′-tggagtgccactgcacaggc-3′
IKK-β3 5′-ggactctgcaatacctggcg-3′
IKK-γ5 5′-cctggagttctccgagcaat-3′
IKK-γ3 5′-gagggaacaggccttaaagg-3′
IκB-α5 5′-ttggtcaggtgaagggagac-3′
IκB-α3 5′-gatcacagccaagtggagtg-3′
IκB-β5 5′-tcctggctctgagtgaggta-3′
IκB-β3 5′-tgcaggagtgttggtggctg-3′
GAPDH-3 5′-gttgccatcaacgaccccttc-3′
GAPDH-5 5′-ctccatggtggtgaagacacc-3′
2386 H. Massaeli et al. / Biochimica et Biophysica Acta 1843 (2014) 2385–2393inﬂammation [18]. To date no data is available on whether CRT plays
any role in NFκB pathway. A role for CRT in immunity and inﬂammatory
process has been shown [19–21]. Our previous studies illustrated that
loss of CRT function results in induction of ER stress, activation of PI3-
kinase/Akt activity and increased ubiquitin–proteasome activity [4,5,
7]. Collectively these data led us to hypothesize that loss of CRT function
will activate NFκB pathway thus increasing the resistance of crt−/−
cells to apoptosis. In contrast, our data shows that gene-targeted dele-
tion of CRT results in suppression of NFκB transcriptional activity. We
also provide evidence that this suppression is due to increased IκBα
stability as a result of the activation of serine–threonine protein
phosphatase, PP2A in crt−/− cells.
2. Materials and methods
2.1. Cell culture and transfection
Wild-type (wt) and CRT-deﬁcient (crt−/−)mouse embryonicﬁbro-
blast cells were established as described previously in [6]. The cells were
regularly cultured in DMEM containing 10% FBS. wt and crt−/− cells
were transfected with reporter plasmid using Lipofectamine 2000
(Life Technologies). Brieﬂy, the cells were transfected with 5–10 μg
DNA and Lipofectamine at a ratio of 1:2 in OPTI-MEM media without
FBS. After 12 h, the transfection mixture was replaced with DMEM
containing 10% FBS. After 48 h the cells were lysed for Western blot or
luciferase reporter gene assay as described below.
2.2. Western blot
wt and crt−/− cell lysates containing 40 μg protein were separated
on a 10% SDS-polyacrylamide gel and blotted to nitrocellulose mem-
brane. After blocking for 1 h with 5% skim milk powder in phosphate-
buffered saline (PBS) the primary antibodies were added and themem-
brane was incubated for 4–16 h. Each nitrocellulose membrane was
stripped and re-probed with cytoskeletal actin or tubulin as a loading
control. HRP-conjugated secondary antibodies (Jackson Laboratories)
were used followed by enhanced chemiluminescence solutions (Santa
Cruz Biotechnology, Inc.). The bands corresponding to each speciﬁc
protein and actin/tubulin were captured by Fluor-S Max (BioRad) and
quantiﬁed using BioRad QuantityOne software. Data were presented
as the ratio of the speciﬁc proteins to the level of actin or tubulin protein.
2.3. Real-time PCR assay
A Qiagen RNAeasy Kit (Qiagen) was used to isolate total RNA from
wt and crt−/− cells. Total RNA was used to synthesize cDNA using
SuperScript II (Life Technologies). Quantitative real-time PCR (QPCR)
was carried out using GO Taq qPCR Master Mix with SYBR Green
(Promega) and an Applied Biosystem 7500 Real-Time PCR Cycler. The
primers for each gene (for mouse) were synthesized by IDT and are
listed in Table 1. Data was analyzed using the software provided by
the Cycler (Applied Biosystem 7500 Real-Time PCR System Analysis)
and was used to calculate the Ct, ΔCt, and ΔΔCt. mRNA expression of
each speciﬁc gene was normalized to the expression of the GAPDH
housekeeping gene, the transcription level of which was not inﬂuenced
under these experimental conditions. The expression of each gene
relative to GAPDHwas calculated as the difference between the thresh-
old values of the two genes (ΔCt). The ΔΔCt value describes the
difference between the average ΔCt value of crt−/− cells and the aver-
age ΔCt value of wt cells. The values are mean ± SE of three separate
experiments carried out in triplicates.
2.4. Ubiquitin pull-down assay
To examine changes in IκBα ubiquitination, a ubiquitin protein
enrichment kit (Millipore)was used.wt and crt−/− cells were culturedin a media containing DMEM and 10% FBS. Cells were treated with
10 μg/ml LPS for 1 h, or Mg132 (20 μg/ml) for 4 h, or a combination of
Mg132 for 4 h and LPS for 1 h. The control group received equal volume
of DMSO. The cells were then lysed with pre-cooled lysis buffer
(containing 50 mM HEPES pH 7.5, 5 mM EDTA, 150 mM NaCl and
1% Triton X-100 with freshly added protease inhibitors and 10 mM
N-ethylmaleimide (NEM)), followed by centrifugation at 10,000
rpm for 10 min. After determination of protein concentration in the
supernatants, 1 mg/ml protein was incubated with 40 μl of afﬁnity
beads at 4 °C overnight with gentle rocking. After the centrifugation
and 3 washes with lysis buffer the beads were resuspended in SDS
loading buffer and resolved on 10% SDS-PAGE, followed by immuno-
blotting with IκBα antibody. An aliquot of the unbound fraction was
also processed for Western blot analysis to examine the non-
ubiquitinated IκBα in the same samples.
2.5. Luciferase activity assay
wt and crt−/−MEF cells were co-transfected with 2 μg pNFκB-LUC
(containing multiple copies of consensus NFκB site, from CloneTech)
and 2 μg β-gal plasmid (as a control for transfection efﬁciency) using Li-
pofectamine 2000 (Life Technologies). 48 h post-transfection, the cells
were lysed using a lysis buffer containing 100 mM Tris pH 7.8, 0.5%
NP40 and 0.5 mM DTT. Cell lysates were centrifuged at 10,000 rpm for
10 min to remove cell debris. Duplicate aliquots of the supernatants
were used for luciferase and β-galactosidase assays as we described in
[6]. Brieﬂy, 100 μl of luciferase assay buffer (containing 470 μM luciferin,
270 μMcoenzymeA, 530 μMATP, 33.3mMDTT, 0.1mMEDTA, 2.67mM
MgSO4, 1.07 mMMgCO3 and 20 mM Tricine) was injected to each tube
containing 20 μl of cell lysate and changes in luminescent were then
measured using a Lumat LB 9507 Luminometer.β-Galactosidase activity
was measured by adding 80 μl ddH2O and 20 μl ONPG (4 mg/ml) to 20
μl of cell lysate. The plateswere incubated at 37 °C for 1 h and the inten-
sity of the developed color wasmeasured at OD420 using a spectropho-
tometer. The ﬁnal results were calculated by normalizing the luciferase
values to β-galactosidase activity. Data were plotted as bar graphs of
mean ± SE of at least 5 independent experiments carried out in
duplicates.
2.6. Immunocytochemistry
To examine changes in NFκB p65 translocation to the nucleus upon
LPS stimulation, wt and crt−/− cells were cultured on glass coverslips
overnight. The cells were then treated with LPS at 37 °C for different
times followed by ﬁxation with ice-cold 4% paraformaldehyde. The cells
were permeabilized with 0.1% Triton X-100 for 15 min at room temper-
ature followed by blockingwith 5% BSA for 1 h. The coverslips were incu-
bated with anti-NFκB p65 antibody (Santa Cruz Biotechnology, Inc.) at
4 °C overnight. On the next day, the coverslips were washed with PBS
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Fig. 1. Transcriptional activity of NFκB is regulated by cellular level of CRT. A) Reporter
geneassay showing a dose-dependent relationship between CRT level andNFκB transcrip-
tional activity. Wild-type (wt), heterozygous CRT knockout (crt+/−) and homozygous
CRT knockout (crt−/−) ﬁbroblasts isolated from mouse embryos were co-transfected
with NFκB-luc and β-gal reporter plasmids. Luciferase and β-gal assays were carried out
as described in theMaterials andmethods. *p b 0.05 and **p b 0.01 are signiﬁcantly differ-
ent fromwt cells. B)wt and crt−/− co-transfected with NFkB-Luc and β-gal were treated
with LPS for 4 h at 37 °C. Cells were then lysed and luciferase and β-gal assays were
carried out. Values represent mean ± SE of six different experiments carried out in
duplicates. *pb 0.05 and **p b 0.01 are signiﬁcantly different from their respective untreat-
ed cells. †p b 0.01 is signiﬁcantly different fromwt cells.
2387H. Massaeli et al. / Biochimica et Biophysica Acta 1843 (2014) 2385–2393and incubated with Alexaﬂour 488-anti-rabbit secondary antibody for
2 h. The coverslips were then washed with PBS and mounted on slides
using anti-fade mounting media containing DAPI (Life Technologies)
to label nuclear DNA. The images were captured using a Leica confocal
microscope.
2.7. NFκB–DNA binding assay
wt and crt−/− cells were treated with or without 10 μg/ml LPS for
60 min. Nuclear extracts were prepared from the cells using Nuclear
Extraction kit (Panomics Inc.) according to the manufacturer's instruc-
tions. The DNA binding activity of NFκB was determined using p65 tran-
scription factor ELISA kit (Panomics Inc.) with some modiﬁcations.
Brieﬂy, the nuclear extracts containing 10 μg protein were incubated
with 40 μl binding buffer mix (containing binding buffer and NFκB-
speciﬁc probe) for 30 min at room temperature, while rocking gently
at 150 rpm. The NFκB–DNA complex was then captured by transferring
the assaymixture to the assay plate, followed by incubation at room tem-
perature for 1 h. The supernatant was then discarded and the wells were
washed three times with wash buffer and incubated with mouse anti-
p65 antibody (1:200 dilution) (Santa Cruz Biotechnology, Inc.) at room
temperature for 1 h. The wells were then washed three times with
wash buffer and incubated with IgG HRP secondary antibody (1:200)
for another hour at room temperature. The wells were washed and the
substrate solution was added and incubated for 10 min; then, the reac-
tion was terminated by adding stop solution. The intensity of the devel-
oped color was determined using a spectrophotometer at OD450 nm.
Blank well received the buffer containing no protein. Data were present-
ed as mean ± SE of three separate experiments conducted in duplicates.
2.8. Protein serine–threonine phosphatase assays
To determine the phosphatase activity in thewt and crt−/− cells,
a ﬂuorescent-based assay kit for serine/threonine was used (Life
Technologies). Phosphatase assays were carried out according to
the manufacturer's protocol. Brieﬂy, the cells were homogenized in
a buffer containing 20 mM HEPES–Tris, pH 7.4, 1 mM PMSF and pro-
tease inhibitors cocktail followed by centrifugation for 10 min. 20 μg
of proteinwas added to eachwell of a 96-well plate containing the phos-
phatase substrate (6,8-diﬂuoro-4-methylumbelliferyl phosphate). The
plate was immediately incubated at 37 °C in the SpectraMax Gemini
Fluorimeter (Molecular Devices). Fluorescent signal was collected
every 5min for a total of 1 h (in kinetic mode) using excitation/emission
wavelength of 358/452 nm. Data were plotted as phosphatase activity at
different time points. Values are mean ± SE of at least 5 independent
experiments carried out in duplicates.
3. Results
3.1. Changes in NFκB activity in CRT-deﬁcient cells
Gene-targeted loss of CRT results in increased resistance to drug-
and UV-induced apoptosis. However, to date there are no data available
on whether CRT can affect NFκB pathway. To test whether CRT affects
NFκB transcriptional activity we examined changes in NFκB reporter
plasmid in MEF cells isolated from the wt, crt+/− and crt−/−mouse
embryos. As shown in Fig. 1A, loss of CRT function resulted in a signiﬁ-
cant decrease in the NFκB reporter gene activity at the basal, non stim-
ulated level. Indeed, there is a direct relationship between the level of
CRT expression and the transcriptional activity of NFκB as shown by
lower NFκB-Luc in the crt+/− cells (Fig. 1A) that express 50% less
CRT compared to that in thewt cells. Fig. 1B shows that LPS stimulation
signiﬁcantly increased NFκB activity in both the wt and crt−/− cells.
However the LPS-mediated increase inNFκB activitywas still signiﬁcantly
less in the crt−/− cells compared to that in thewt cells treated with LPS
and non-treated (Fig. 1B).Activation of NFκB pathway encompasses modiﬁcation of several
proteins. To examine whether the decreased NFκB activity observed in
CRT-deﬁcient cells is due to changes in the expression of proteins
involved in this pathway we carried out Western blot analysis. Fig. 2A
and B illustrates a signiﬁcant increase in both NFκB p65 and IκBα
protein levels in crt−/− cells compared to those in the wt cells. We
observed no differences in the NFκB p50 protein expression between
the two cell lines. Changes in protein level could be due to increased
transcription/translation or protein stability. To explore the possibility
of any alteration at the mRNA level of these proteins, quantitative
real-time PCR was carried out using gene-speciﬁc primers as described
in the Materials and methods. Table 2 summarizes the relative changes
in mRNA of these genes in crt−/− cells normalized to the wt cells. As
shown in Table 2, there was no signiﬁcant change in IκBβ and NFκB
(p65) mRNA in crt−/− cells. Interestingly, the mRNA level of IKKα,
IKKβ, IKKγ, and IκBαwas increased by 200%, 25%, 89% and 29% respec-
tively, in the crt−/− cells compared to that in the wt cells. These data
suggest that the observed increase in IκBα, and NFκB protein could be
due to their increased protein stability in CRT-deﬁcient cells.
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Fig. 2. NFκB and IκB protein expression in the crt−/− cells. A) Representative Western
blots showing higher expression of p65 and IκB protein in the crt−/− cells as compared
to that in thewt cells. B) Bar graph shows quantiﬁcation of protein band density presented
as the ratio of each protein to their respective actin band density. Values aremean± SE of
four independent experiments. *p b 0.05, signiﬁcantly different from the wt.
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Agonist-mediated activation of NFκB is associated with the phos-
phorylation of IκB followed by its ubiquitination and degradation via
the ubiquitin–proteasome pathway [13,14]. To determine changes in
IκB following stimulation of NFκB, wt and crt−/− cells were treated
with LPS in a time-dependent manner. As shown in Fig. 3A, LPS
stimulation of thewt cells resulted in a signiﬁcant decrease in IκBα pro-
tein reaching the lowest level of protein following 30min LPS treatment
due to its ubiquitination and degradation. Longer exposure to LPS (more
than 60 min) resulted in the recovery of IκBα protein level in the wt
cells. Treatment of crt−/− cells with LPS also resulted in decreased
IκBα protein, however the extent of this decrease was signiﬁcantly
less than that in the wt cells and it required longer LPS treatment
(Fig. 3A, lower panel).3.3. Nuclear translocation and DNA binding of NFκB crt−/− cells
To examinewhether the LPS-mediated changes in IκBα level affected
NFκB p65 nuclear translocation and its function, we examined the sub-
cellular localization of p65 protein in cells following treatment withTable 2
Real-time PCR analysis showing mRNA expression pattern of NFκB
family members in the crt−/− cells as compared to that in thewt cells.
Gene Relative mRNA expression
level of crt−/−/wt
IKKα 3.01 ± 0.38
IKKβ 1.25 ± 0.07
IKKγ 1.89 ± 0.25
IκBα 1.29 ± 0.03
IκBβ 1.08 ± 0.01
NFκBp65 1.15 ± 0.07
Values represent normalized target gene expression of crt−/− versus
wt cells. Data are presented as means ± SE of three different
experiments carried out in triplicates.LPS. As seen in Fig. 3B, short time treatment with LPS (10–15 min) did
not result in nuclear localization of NFκB p65 in wt or crt−/− cells. On
the other hand, 30 min LPS stimulation resulted in nuclear translocation
of NFκB p65 in all the wt cells, however, in crt−/− cells p65 was still
localized in the cytoplasm after 30min LPS stimulation (Fig. 3B). Follow-
ing 60 min stimulation with LPS, p65 was localized to the nucleus of
some of the crt−/− cells albeit to a lesser extent than that in the wt
cells. To investigate whether the altered nuclear localization of NFκB
affected its DNA-binding ability thus causing the reduced transcriptional
activity of NFκB in crt−/− cells, nuclear extracts were prepared from
non-treated and LPS-treated wt and crt−/− cells. NFκB–DNA binding
assay was performed as described in the “Materials and methods”. As
shown in Fig. 3C, the basal NFκB (p65) DNA binding was signiﬁcantly
reduced in CRT-deﬁcient cells. Stimulating the cells for 60 min with
LPS resulted in an increase in NFκB (p65) DNA binding in both the wt
and crt−/− cells, however, the p65 DNA binding in the crt−/− cells
was signiﬁcantly lower than that in the wt cells. Overall, our data
suggests that NFκB activity is impaired upon loss of CRT function.
3.4. IκB phosphorylation in CRT-deﬁcient cells
Activation of NFκB is associatedwith phosphorylation of its signaling
molecules. In fact, IKK complex, IκBα and both NFκB heterodimer
proteins (p65 and p50) are subjected to phosphorylation by related
kinases. Alternatively, de-phosphorylation of these molecules by
speciﬁc phosphatases can modulate the activity of these proteins
[22]. Both LPS stimulation and TNFα stimulation have been shown
to activate IKK-mediated IκBα phosphorylation [12,23]. Thus we
examined if loss of CRT function affects IκBα phosphorylation, cells
were treated with LPS for different times and Western blot with an-
tibody speciﬁc to P-IκBα (seine 32) was carried out. Fig. 4 shows
changes in the expression of P-IκBα, IκBα and actin following LPS
treatment at different times. In control non-treated wt and crt−/−
cells P-IκBα was at very low level. As shown in Fig. 4A, LPS induced
phosphorylation of IκBα protein in both the wt and crt−/− cells.
Furthermore, P-IκBα level was signiﬁcantly higher in crt−/− cells at
all different time points of LPS treatment. The level of IκBα protein
was also higher at all different times of LPS treatment in crt−/− cells
as compared to that in wt cells (Fig. 4B). Table 2 also illustrates that in
the CRT-deﬁcient cells, the mRNA expression of all three isoforms of
IKK is signiﬁcantly higher compared to that in the wt cells. These data
suggest that the limiting factor in IκBα degradation in CRT-deﬁcient
cells is not its phosphorylation but rather it could be due to its rapid
de-phosphorylation or its ubiquitination.
3.5. IκB dephosphorylation in CRT-deﬁcient cells
A role for PP2A in dephosphorylating different molecules in the
NFκB pathway has been reported previously [24,25]. Moreover, okadaic
acid-mediated inhibition of PP2A has been reported to increase phos-
phorylation and degradation of IκBα and continuous NFκB activation
[23]. Indeed, in our preliminary quantitative proteomic analysis of the
crt−/− cells we observed a signiﬁcant increase in the expression of dif-
ferent subunits of serine–threonine protein phosphatase PP2A and PP4
(2-fold and 7-fold respectively, our unpublished data). PP4 shares a
high degree of homology to PP2A [26]. To investigate the changes in
PP2A activity upon loss of CRT functionwe used a ﬂuorescent-based en-
zyme assay as described in the “Materials and methods”. As shown in
Fig. 5A, there was a signiﬁcant increase in PP2A activity in the crt−/−
cells as compared to that in the wt cells. Okadaic acid is a serine–
threonine inhibitor with an IC50 of 0.1 nM for PP2A and 0.4 nM for
PP4. Addition of okadaic acid to the phosphatase assay was able to
inhibit the activity of PP2A completely (data not shown). Next, we
examined the effect of inhibition of PP2A by okadaic acid on IκBα
protein level. Fig. 5B illustrates that prolonged treatment of the cells
(5 h) with okadaic acid signiﬁcantly reduced the basal level of IκBα
2389H. Massaeli et al. / Biochimica et Biophysica Acta 1843 (2014) 2385–2393protein in both the wt and crt−/− cells. Interestingly, the decrease in
the IκBα protein in crt−/− cells was greater than the decrease in wt
cells, in fact the IκBα protein level was reduced to the same level in
both of the cells following okadaic acid treatment.
Fig. 5C illustrates that inhibition of PP2A by okadaic acid (2 h) leads
to a signiﬁcant accumulation of P-IκBα protein in the crt−/− cells
treated with LPS for 30 or 60min. The increase in P-IκBαwas accompa-
nied by a signiﬁcant decrease in IκBα protein in crt−/− cells as com-
pared to that in the wt cells or crt−/− cells not treated with okadaic
acid. Overall, these data illustrates the role of increased PP2A activity
in the regulation of IκBα protein upon loss of CRT function.3.6. Ubiquitination of IκB in crt−/− cells
To test how loss of CRT function affects ubiquitination of IκBα,wt
and crt−/− cells were treated with proteasome inhibitor MG132 or
with a combination of MG132 and LPS (as described in the Materials
and methods). As shown in Fig. 6 in control cells the level of
ubiquitinated IκBα was not detectable in the wt cells but a small
amount of IκBα was ubiquitinated in the crt−/− cells. In addition,
the total non-ubiquitinated IκBα was signiﬁcantly higher in the
crt−/− cells compared to that in the wt. Inhibition of proteasome
with MG132 resulted in accumulation of ubiquitinated IκBα in
both cell types with a higher level of ubiquitinated IκBα observed in
wt cells as compared to that in the crt−/− cells (Fig. 6, upper panel).
Interestingly no difference was observed in the non-ubiquitinated
IκBα in both of the cells (Fig. 6, lower panel). As shown in Fig. 6,
upper panel, LPS stimulation slightly increased ubiquitinated IκBα pro-
tein inwt cells. This could be attributed to increased degradation of IκBα
upon LPS stimulation and is supported by reduced non-ubiquitinated
IκBα level in the unbound fraction.A
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Fig. 3. Time-dependent effect of LPS on IκBα protein level in wt and crt−/− cells. A) Cells we
Western blot using IκBα-speciﬁc antibodies. B) Immunocytochemical staining of NFκB (p65)
cells.wt and crt−/− cells were grown on coverslips overnight then treated with LPS for the du
chemistry to detect p65 (FITC, green) localization as described in theMaterials andmethods. DA
DNA binding in thewt and crt−/− cells. The nuclear extracts isolated from control and LPS-trea
in theMaterials andmethods. Data shown aspercentage change relative towt non-treated cells.
wt cells.To examine the role of proteasome in the LPS-induced decrease in
IκBα proteins, the cells were pre-treated with a proteasome inhibitor
MG132 for 3 h followed by addition of LPS in the presence of MG132
for an additional 1 h. As shown in Fig. 6, pre-treatment with MG132
inhibited LPS-induced degradation of IκBα via proteasomes in both wt
and crt−/− cells. This treatment also resulted in a similar level of
non-ubiquitinated IκBα in both cell types.
4. Discussion
NFκB family proteins are transcription factors that have several
members including p65 (RelA), NFκB1 (p50; p105), NFκB2 (p52;
p100), c-Rel andRelB. TheN-terminal domain of these proteins includes
the dimerization, nuclear localization and DNA-binding domains [10].
Activation of NFκB transcription in the cell is mediated by two main
physiological pathways depending on the type of stimuli. Inﬂammatory
cytokines (e.g. TNFα), pathogenic molecules and antigen receptors
induce the canonical pathway [12,23], while the non-canonical path-
way is activated by factors such as β-cell activating factor and CD40L
[27]. The non-canonical pathway stimulation involves IKKα activation
that induces degradation of p100 to increase p52 level and formation
of p52/RelB dimer [27]. Stimulation of the canonical pathway activates
IKKβ and IKKγ (NEMO) complex. Activated IKKβ/IKKγ phosphorylates
IκB followed by its ubiquitination and degradation [11,12]. Degradation
of IκB releases p65/p50 dimer that will then translocate to the nucleus
where it mediates transcription of downstream target genes [13]. Acti-
vation of NFκB has been shown to induce expression of cell dhesion
molecule [28], matrix metalloproteinase-9 [29], genes involved in
esistance to apoptosis [30], genes regulating cell proliferation [31], and
chemokine production [32].
Mutation in IκB protein that results in its truncation [33] or in-
creases its degradation due to enhanced ubiquitination or proteasome0
crt-/-
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re treated with 10 μg/ml LPS for different times (as indicated). Cell lysates were used for
showed impaired nuclear translocation in the crt−/− cells as compared to that in the wt
ration indicated. The cells were ﬁxed in 4% para-formaldehyde, followed by immunocyto-
PI (blue)was used to stain the nucleus. C) Bar graph shows basal- and LPS-inducedNFκB–
ted (10 μg/ml)wt and crt−/− cells were utilized for NFκB–DNAbinding assay as described
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Similarly, up-regulation of inﬂammatory cytokines [9] and growth
factor-driven or constitutive activation of PI3 kinase/Akt signaling path-
waywere also shown to induceNFκB activity [35,36]. A role for ER stress
in induction of NFκB transcription has also been reported [15]. There are
nodata on the role of ER chaperones onNFκB transcription or vice versa.
Previous research from our lab showed that gene-targeted deletion
of CRT in mouse activates agonist-mediated PI3-kinase/Akt activity [7],
increases ubiquitin–proteasome activity [5] and elevates ER stress [4].
Our lab and others also demonstrated that CRT-deﬁcient MEF cells are
resistant to apoptosis [6,8]. Despite these evidences, in the current
study we showed for the ﬁrst time that CRT-deﬁcient cells exhibit
lower NFκB transcriptional activity at the basal level and upon LPS
stimulation (Fig. 1A,B). Interestingly, we showed a correlation between
the level of CRT expression and NFκB transcriptional activity (Fig. 1A,B).
Although treatment with LPS was able to increase NFκB activity in both
wt and crt−/− cells, this activity was still signiﬁcantly lower in crt−/−
cells as compared to that in the non-treated wt cells (Fig. 1B). Indeed,
we previously reported that the mRNA and protein levels of matrix
metalloproteinase-9, one of the downstream targets of NFκB, are
signiﬁcantly decreased in crt−/− cells [37]. Furthermore, we haveobserved a signiﬁcant decrease in protein levels of vascular cell adhe-
sion molecule-1 (VCAM-1) and cyclin D1 (two other known targets of
NFκB) in the crt−/− cells (our unpublished data). These data supports
our current ﬁndings of decreased NFκB upon loss of CRT function.
Suppressed NFκB activity in the crt−/− cells could be due to several
factors including: altered expression of different proteins of this path-
way at the synthesis or degradation level, defects in nuclear transloca-
tion of p65/p50, or degradation of IκB. Our data presented in this
report showed that the protein level of p65 and that of IκB were signif-
icantly increased and p50 did not change (Fig. 2A,B). These observations
suggest that protein level is not the limiting factor. Previously, we
showed a defect in the nuclear translocation of p53 and NFATc1 to the
nucleus of the crt−/− cells [6,38] that resulted in suppression of their
transcription activities. Lynch et al. [39] also reported a similar defect
in MEF2C nuclear translocation and transcriptional activity in CRT-deﬁ-
cient cells. However, nuclear translocation of p65 seems to be not a lim-
iting factor in the NFκBα transcriptional activity in the absence of CRT.
As shown in Fig. 3B p65 translocates to the nucleus in the crt−/−
cells albeit to a lesser extent as compared to that in the wt cells, and it
requires longer time of exposure to LPS (60 min) for this translocation.
Once in the nucleus p65 will bind to the DNA, however the binding is
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measurement of PP2A activity over 60 min time period as described in the Materials and methods. Data are mean ± SE of six different experiments carried out in duplicates. *p b 0.05,
signiﬁcantly different from the wt cells. B) A representative Western blot shows (n = 3) that prolonged inhibition of PP2A by okadaic acid (5 h) decreases IκBα level to a greater extent
in the crt−/− cells as compared to that in thewt cells. C) RepresentativeWestern blot (n= 4) showing that okadaic acid (OKA) treatment increases P-IκBα accumulation in the crt−/−
cells following LPS stimulation. The cellswere treatedwith LPS in the presence and absence of okadaic acid followed by lysis andWestern blot for P-IκBα and IκBα. Western blotwith anti-
actin antibody was carried out on the same blot as a loading control.
wt crt-/- wt crt-/- wt crt-/- wt crt-/- 
Unbound  
IκBα 
Ub-IκBα 
MG132 Control LPS LPS+MG132 
Fig. 6. Effect of inhibition of proteasome activity on IκBα levels in the crt−/− cells. Thewt
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in the Materials and methods. Western blot was then carried out on the ubiquitin pull-
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cells (Fig. 3C). Thus, we ruled out the defect in nuclear translocation
and DNA binding as the cause of decreased NFκB activity in the
crt−/− cells. After termination of stimulation the newly synthesized
IκBα mediates nuclear export of p65/p50 [13]. Previous report by
Holaska et al. [40] showed that CRT plays a role in the nuclear export
of glucocorticoid receptor. However, any role of CRT in the export of
p65/p50 could be ruled out because in the absence of CRT one would
expect accumulation of p65 in the nucleus that can induce increased
transcriptional activity of p65. Thus, the reduced nuclear localization
and DNA binding activity of p65 in the crt−/− cells could be attributed
to the increased IκBα stability that can reduce the level of free p65 in the
crt−/− cytoplasm. In addition, our data shows a signiﬁcant increase in
the IκBαmRNA expression (Table 2) and protein (Fig. 2) in the crt−/−
cells as compared to that in the wt cells.
The p65/p50 function is tightly regulated by binding to the inhibito-
ry IκB, the thirdmember of this trimer [9]. IKKβ-mediated phosphoryla-
tion of IκB results in its subsequent ubiquitination and degradation [10];
2393H. Massaeli et al. / Biochimica et Biophysica Acta 1843 (2014) 2385–2393thus, diminished IκB phosphorylation could increase its stability. In-
deed, we showed a signiﬁcant increase in IκBα protein level in the
crt−/− cells (Fig. 2), which can decrease the free p65/p50 dimer
level.We also showed increasedmRNA expression of the three isoforms
of IKK in the crt−/− cells as compared to that in thewt cells (Table 2).
Interestingly, following LPS stimulation the level of both P-IκBα and
IκBα was signiﬁcantly higher in the crt−/− cells as compared to that
in the wt cells at all time points tested (Fig. 5C), which can be due to
both increased IκBα protein level and IKK activity. We also illustrated
that the increased IκBα was partially due to a signiﬁcant activation of
PP2A (Fig. 5A), as inhibition of this phosphatase by okadaic acid resulted
in a signiﬁcant reduction of IκBα protein level in both cells (Fig. 5B).
Furthermore, our data in Fig. 5C shows that in the absence of CRT, phos-
phorylated IκBα is rapidly dephosphorylated due to the high PP2A
activity (Fig. 5A) andwhen PP2A is suppressed by okadaic acid it results
in the accumulation of higher phosphorylated IκB and reduced non-
phosphorylated IκB in the crt−/− cells. These data suggested an
increase in the stability of IκB in the absence of CRT.
In conclusion, our data demonstrates that loss of CRT function de-
creases NFκB function indirectly by increasing IκB stability. To our
knowledge this is the ﬁrst report showing a correlation between NFκB
signaling pathway and cellular level of CRT. Understanding the underly-
ing molecular mechanisms of CRT involvement in the regulation of
NFκB activity could potentially elucidate the new reports about the
role of CRT in immune response.
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